1332 — Touyun Biotech Share Price
Last trade - 00:00- HK$488.24m
- HK$845.74m
- HK$159.97m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.05 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -48.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 206.79 | 283.5 | 315.82 | 198.64 | 159.97 | n/a | n/a | -14.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, is an investment holding company principally engaged in the manufacture and sales of packaging products. Along with subsidiaries, the Company operates its business through four segments. The Packaging Products segment is engaged in the production and sale of manufacture and sale of watch boxes, jewelry boxes, eyewear cases, bags and pouches and display units. The Quick Response (QR) Code Business segment is engaged in the provision of QR code on product packaging and solutions and advertising display services. The Chlamydomonas Reinhardtii Product Business segment is engaged in the production and sale of chlamydomonas reinhardtii, micro-algae and related products. The Treasury Investment segment is engaged in the investments and trading in securities, money lending, securities brokerage and margin financing.
Directors
- Liang Wang CHM (31)
- Amy Ha CEO (50)
- Dong Du EDR (30)
- Yuen Wa Lo EDR (53)
- Nga Yan Wong SEC
- Hui Chen NED (57)
- Wenjie Jie NED (35)
- Zhang Lele NED (36)
- Yuze Tian NED (28)
- Wing Ping Cheung NID (49)
- Kee Choy Ha NID (64)
- Guohua Hu NID (46)
- Shing Chuen To NID (65)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 24th, 2011
- Public Since
- July 12th, 2012
- No. of Employees
- 485
- Sector
- Containers & Packaging
- Industry
- Basic Materials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,805,952,000
- Address
- 7th Floor, China United Centre
- Web
- https://touyunbiotech.com.hk/
- Phone
- +852 null22707200
- Auditors
- Moore CPA Limited
Upcoming Events for 1332
Similar to 1332
China Aluminum Cans Holdings
Stock Exchange of Hong Kong Limited
China Treasures New Materials
Stock Exchange of Hong Kong Limited
Come Sure (Holdings)
Stock Exchange of Hong Kong Limited
COSCO SHIPPING Development Co
Stock Exchange of Hong Kong Limited
Daisho Microline Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:44 UTC, shares in Touyun Biotech are trading at HK$0.17. This share price information is delayed by 15 minutes.
Shares in Touyun Biotech last closed at HK$0.17 and the price had moved by -27.5% over the past 365 days. In terms of relative price strength the Touyun Biotech share price has underperformed the FTSE Developed Asia Pacific Index by -26.67% over the past year.
There is no consensus recommendation for this security.
Find out moreTouyun Biotech does not currently pay a dividend.
Touyun Biotech does not currently pay a dividend.
Touyun Biotech does not currently pay a dividend.
To buy shares in Touyun Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.17, shares in Touyun Biotech had a market capitalisation of HK$488.24m.
Here are the trading details for Touyun Biotech:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1332
Based on an overall assessment of its quality, value and momentum Touyun Biotech is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Touyun Biotech. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +15.96%.
As of the last closing price of HK$0.17, shares in Touyun Biotech were trading +0.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Touyun Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Touyun Biotech's management team is headed by:
- Liang Wang - CHM
- Amy Ha - CEO
- Dong Du - EDR
- Yuen Wa Lo - EDR
- Nga Yan Wong - SEC
- Hui Chen - NED
- Wenjie Jie - NED
- Zhang Lele - NED
- Yuze Tian - NED
- Wing Ping Cheung - NID
- Kee Choy Ha - NID
- Guohua Hu - NID
- Shing Chuen To - NID